Parkside Financial Bank & Trust’s Alerian MLP Index ETNs due January 28 2044 AMJB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$964K Sell
27,884
-13,940
-33% -$465K 0.07% 160
2025
Q4
$1.25M Sell
41,824
-10,252
-20% -$305K 0.09% 133
2025
Q3
$1.54M Sell
52,076
-8,190
-14% -$248K 0.12% 117
2025
Q2
$1.82M Sell
60,266
-45,437
-43% -$1.37M 0.2% 97
2025
Q1
$3.43M Sell
105,703
-69,123
-40% -$2.22M 0.44% 49
2024
Q4
$5.16M Sell
174,826
-101,638
-37% -$2.99M 0.68% 24
2024
Q3
$7.87M Sell
276,464
-96,438
-26% -$2.76M 1.1% 18
2024
Q2
$10.8M Buy
+372,902
New +$10.5M 1.69% 8

Other funds holding AMJB

Parkside Financial Bank & Trust's AMJB Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Alerian MLP Index ETNs due January 28 2044 (AMJB) stake by 33% in Q1 2026, selling an estimated $465K and leaving 27,884 shares worth $964K. The position accounts for 0.07% of the portfolio, ranked #160.

Parkside Financial Bank & Trust first reported a position in AMJB in Q2 2024 and has held it in 8 quarters since. The position peaked at $10.8M in Q2 2024. 70 funds tracked by Wall St. Rank hold AMJB as of Q1 2026.

  • Parkside Financial Bank & Trust held 27,884 shares of Alerian MLP Index ETNs due January 28 2044 worth $964K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 13,940 Alerian MLP Index ETNs due January 28 2044 shares in Q1 2026, an estimated $465K.
  • Alerian MLP Index ETNs due January 28 2044 made up 0.07% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #160 holding.
  • Parkside Financial Bank & Trust first reported a position in Alerian MLP Index ETNs due January 28 2044 in Q2 2024 and has held it in 8 quarters since.
  • Parkside Financial Bank & Trust's Alerian MLP Index ETNs due January 28 2044 position peaked at $10.8M in Q2 2024.
  • 70 funds tracked by Wall St. Rank held Alerian MLP Index ETNs due January 28 2044 as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.